Original Research
Published on 30 Apr 2021
Resibufogenin Suppresses Triple-Negative Breast Cancer Angiogenesis by Blocking VEGFR2-Mediated Signaling Pathway
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.682735
- 6,391 views
- 16 citations



